Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP. Issue 1 (15th February 2019)
- Record Type:
- Journal Article
- Title:
- Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP. Issue 1 (15th February 2019)
- Main Title:
- Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP
- Authors:
- Branford, David
Gerrard, David
Saleem, Nigget
Shaw, Carl
Webster, Anne - Abstract:
- Abstract : Purpose: The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme. Design/methodology/approach: The review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both. Findings: The review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours. Originality/value: STOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system areAbstract : Purpose: The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme. Design/methodology/approach: The review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both. Findings: The review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours. Originality/value: STOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities, autism or both who have a mental illness or whose behaviour challenges services. This review identifies many studies, programmes and guidelines associated with psychotropic drug use for people with an intellectual disability, autism or both. … (more)
- Is Part Of:
- Advances in mental health and intellectual disabilities. Volume 13:Issue 1(2019)
- Journal:
- Advances in mental health and intellectual disabilities
- Issue:
- Volume 13:Issue 1(2019)
- Issue Display:
- Volume 13, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 13
- Issue:
- 1
- Issue Sort Value:
- 2019-0013-0001-0000
- Page Start:
- 31
- Page End:
- 40
- Publication Date:
- 2019-02-15
- Subjects:
- Autism -- Intellectual disability -- Learning disability -- Polypharmacy -- Call to action methodology -- Psychotropic drugs
Learning disabled -- Mental health services -- Great Britain -- Periodicals
362.30941 - Journal URLs:
- http://www.emeraldinsight.com/journals.htm?issn=2044-1282 ↗
http://www.pierprofessional.com/amhldflyer/ ↗
http://www.emeraldinsight.com/ ↗ - DOI:
- 10.1108/AMHID-02-2018-0004 ↗
- Languages:
- English
- ISSNs:
- 2044-1282
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9618.xml